A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 Diabetes

Clinical trial NCT01606397 · COMPLETED

Trial details

NCT number: NCT01606397
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2008-03-01
Primary completion: 2008-11-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.